robincelery056
の編集
https://nativ.media:443/wiki/index.php?robincelery056
[
トップ
] [
編集
|
差分
|
バックアップ
|
添付
|
リロード
] [
新規
|
一覧
|
単語検索
|
最終更新
|
ヘルプ
]
-- 雛形とするページ --
stemplate9
systemplate1
anglewealth29
augustwing79
bailcanoe0
bicycle
blacksquid7
BracketName
bullbadger65
chat
cherryview36
congoash26
coversyria93
crowdorder4
crowrat5
dinnerchalk84
dirtspark8
divingtailor5
fireddrink41
FormattingRules
FrontPage
garliccrop28
girdlecough25
heatcannon64
Help
heronshare1
homeblue7
hookgate1
horsereport2
InterWiki
InterWikiName
InterWikiSandBox
irangrease8
jeepwound62
jumpsign8
lacebotany0
lacebush04
laughflare40
libratax78
lumberflag1
management
mantip8
markagenda9
MenuBar
mosquesharon9
nodemarket9
ovensquid5
partybubble42
peanutnorth22
peenperch5
perchbobcat43
periodbroker2
personformat66
petcrab68
petsteel08
pizzaamount7
puffinchest0
PukiWiki
PukiWiki/1.4
PukiWiki/1.4/Manual
PukiWiki/1.4/Manual/Plugin
PukiWiki/1.4/Manual/Plugin/A-D
PukiWiki/1.4/Manual/Plugin/E-G
PukiWiki/1.4/Manual/Plugin/H-K
PukiWiki/1.4/Manual/Plugin/L-N
PukiWiki/1.4/Manual/Plugin/O-R
PukiWiki/1.4/Manual/Plugin/S-U
PukiWiki/1.4/Manual/Plugin/V-Z
quailbobcat51
radishparty6
rakefelony1
rakegym4
rawqan
RecentDeleted
riverdriver7
rosething88
rubberbrace0
saladcanada3
saltneed41
SandBox
scentclass47
selectneck8
shelftooth73
silicacell53
silicadress66
spheretulip3
startsale4
streamview45
supplylook2
sushilocket2
swimcrook5
taxi
thrillcrime5
trouthead87
tulipskin2786
versecrow43
vesselsteel94
vestpull15
WikiEngines
WikiName
WikiWikiWeb
YukiWiki
...
MiR-138-5p was down-regulated in H/R-induced H9C2 cells. circSAMD4A was a targeted regulator of miR-138-5p. CircSAMD4A inhibited the expression of miR-138-5p to promote H/R-induced myocardial cell injury in vitro and vivo. In conclusion, CircSAMD4A can sponge miR-138-5p to promote H/R-induced apoptosis and inflammatory response. To assess the agreement between patient-reported and health care provider-reported medical information in inflammatory bowel disease (IBD). This multicentre, prospective, event monitoring study enrolled adult Crohn's disease (CD) and ulcerative colitis (UC) patients treated with a biological in four medical centers in the Netherlands. At two-monthly intervals, patients completed questionnaires on biological use, combination therapy and indication. The patient-reported information was compared with their electronic health records (EHRs) and analysed for percentage agreement and Cohen's kappa. A reference population from a prospective IBD registry was used to assess the representativeness of the study population. In total, 182 patients (female 50.5%, mean age 42.2 years, CD 76.9%) were included in the analysis. At baseline, 51.0% of the patients were prescribed an immunomodulator (43.9% thiopurines, 7.1% methotrexate), and patients were prescribed biologicals as follows 59.3% infliximab, 30.2% adalimumab, 9.3% vedolizumab, and 1.1% ustekinumab. Agreement on patient-reported indication and biological use was almost perfect (κ = 0.878 and κ = 1.000, respectively); substantial for combination therapy (κ = 0.672). Gender, age, type of IBD, biological use and combination therapy were comparable with the reference population. Systematic patient-reporting by questionnaires was reliable in retrieving indication and treatment specific information from IBD patients. These results indicate that the use of patient-reporting outcomes in daily IBD practice can ensure reliable information collection.Systematic patient-reporting by questionnaires was reliable in retrieving indication and treatment specific information from IBD patients. These results indicate that the use of patient-reporting outcomes in daily IBD practice can ensure reliable information collection.In February 2020, the Organ Procurement and Transplantation Network replaced donor service area-based allocation of livers with acuity circles, a system based on three homogeneous circles around each donor hospital. This system has been criticized for neglecting to consider varying population density and proximity to coast and national borders. https://www.selleckchem.com/ Using Scientific Registry of Transplant Recipients data from 07/2013-06/2017, we designed novel, heterogeneous circles to reduce both circle size and variation in liver supply/demand ratios across transplant centers. We weighted liver demand by MELD/PELD because higher MELD/PELD candidates are more likely to be transplanted. Transplant centers in the West had the largest circles; transplant centers in the Midwest and South had the smallest circles. Supply/demand ratios ranged from 0.471 to 0.655 livers per MELD-weighted incident candidate. Our heterogeneous circles had lower variation in supply/demand ratios than homogeneous circles of any radius between 150-1,000 nm. Homogeneous circles of 500 nm, the largest circle used in the acuity circles allocation system, had a variance in supply/demand ratios 16 times higher than our heterogeneous circles (0.0156 vs 0.0009) and a range of supply/demand ratios 2.3 times higher than our heterogeneous circles (0.421 vs 0.184). Our heterogeneous circles had a median (IQR) radius of only 326 (275-470) nautical miles, but reduced disparities in supply/demand ratios significantly by accounting for population density, national borders, and the geographic variation of supply and demand. In conclusion, large homogeneous circles create logistical burdens on transplant centers that do not need them, while small homogeneous circles increase geographic disparity. Using carefully designed heterogeneous circles can reduce geographic disparity in liver supply/demand ratios, compared to homogeneous circles of radius ranging from 150-1,000 nm.HLA-DQB1*05272 has a single transversion compared to the most similar variant, HLA-DQB1*050101 in IPD-IMGT/HLA database. To evaluate the effectiveness of the application of topical heat, high pressure or a combination of both on antebrachial venous cannulation. A cross-over clinical trial blinded for haemolysis analysis. This cross-over clinical trial with two periods was performed in the Clinical Trial Unit of Hospital Universitario de La Princesa (Madrid) during June-July of 2017 in 59 healthy adults who were randomly allocated to one of three interventions (1) Using dry topical heat for 7min produced by two hot seed bags (N=21), (2) Applying controlled pressure from a sphygmomanometer inflated to 100mmHg (N=18) and (3) combining heat and pressure (N=20) in one period out of two. All interventions were contrasted to standard clinical practice in the other period. The comparator involved a standard tourniquet around the upper arm to restrict venous blood flow. The primary outcome was effectiveness measured as vein cannulation at first attempt. Secondary outcomes were vein perception, pain, haemolysis in blood samples andwho often suffer from arterial hypertension. Ultrasonic scalers often cause an uncomfortable feeling to patients during the procedure. This study was conducted to compare patient complaint levels between magnetostrictive (M-USSC) and piezoelectric ultrasonic scalers (P-USSC) during supragingival scaling. This study enrolled 82 subjects who received supportive periodontal therapy for at least 2years. At each recall visit, probing pocket depth (PPD), bleeding on probing (BOP) and O'Leary plaque control record (O'PCR) were recorded. Then, supragingival scaling was performed using P-USSC (Varios or Petit Piezo) at the first visit and M-USSC (Cavitron) at the second visit. After each treatment, a questionnaire survey was performed using the Wong-Baker Faces Pain Scale for six items, which included the typical complaints occurring during ultrasonic scaling. The scores for all the six items related to patient complaints were greater for P-USSC than for M-USSC (p<0.001). Patient complaints such as discomfort, pain, sound, vibration, hyperesthesia and length of treatment time were ameliorated in 74%, 65%, 80%, 67%, 57% and 53% of subjects using M-USSC, respectively.
タイムスタンプを変更しない
MiR-138-5p was down-regulated in H/R-induced H9C2 cells. circSAMD4A was a targeted regulator of miR-138-5p. CircSAMD4A inhibited the expression of miR-138-5p to promote H/R-induced myocardial cell injury in vitro and vivo. In conclusion, CircSAMD4A can sponge miR-138-5p to promote H/R-induced apoptosis and inflammatory response. To assess the agreement between patient-reported and health care provider-reported medical information in inflammatory bowel disease (IBD). This multicentre, prospective, event monitoring study enrolled adult Crohn's disease (CD) and ulcerative colitis (UC) patients treated with a biological in four medical centers in the Netherlands. At two-monthly intervals, patients completed questionnaires on biological use, combination therapy and indication. The patient-reported information was compared with their electronic health records (EHRs) and analysed for percentage agreement and Cohen's kappa. A reference population from a prospective IBD registry was used to assess the representativeness of the study population. In total, 182 patients (female 50.5%, mean age 42.2 years, CD 76.9%) were included in the analysis. At baseline, 51.0% of the patients were prescribed an immunomodulator (43.9% thiopurines, 7.1% methotrexate), and patients were prescribed biologicals as follows 59.3% infliximab, 30.2% adalimumab, 9.3% vedolizumab, and 1.1% ustekinumab. Agreement on patient-reported indication and biological use was almost perfect (κ = 0.878 and κ = 1.000, respectively); substantial for combination therapy (κ = 0.672). Gender, age, type of IBD, biological use and combination therapy were comparable with the reference population. Systematic patient-reporting by questionnaires was reliable in retrieving indication and treatment specific information from IBD patients. These results indicate that the use of patient-reporting outcomes in daily IBD practice can ensure reliable information collection.Systematic patient-reporting by questionnaires was reliable in retrieving indication and treatment specific information from IBD patients. These results indicate that the use of patient-reporting outcomes in daily IBD practice can ensure reliable information collection.In February 2020, the Organ Procurement and Transplantation Network replaced donor service area-based allocation of livers with acuity circles, a system based on three homogeneous circles around each donor hospital. This system has been criticized for neglecting to consider varying population density and proximity to coast and national borders. https://www.selleckchem.com/ Using Scientific Registry of Transplant Recipients data from 07/2013-06/2017, we designed novel, heterogeneous circles to reduce both circle size and variation in liver supply/demand ratios across transplant centers. We weighted liver demand by MELD/PELD because higher MELD/PELD candidates are more likely to be transplanted. Transplant centers in the West had the largest circles; transplant centers in the Midwest and South had the smallest circles. Supply/demand ratios ranged from 0.471 to 0.655 livers per MELD-weighted incident candidate. Our heterogeneous circles had lower variation in supply/demand ratios than homogeneous circles of any radius between 150-1,000 nm. Homogeneous circles of 500 nm, the largest circle used in the acuity circles allocation system, had a variance in supply/demand ratios 16 times higher than our heterogeneous circles (0.0156 vs 0.0009) and a range of supply/demand ratios 2.3 times higher than our heterogeneous circles (0.421 vs 0.184). Our heterogeneous circles had a median (IQR) radius of only 326 (275-470) nautical miles, but reduced disparities in supply/demand ratios significantly by accounting for population density, national borders, and the geographic variation of supply and demand. In conclusion, large homogeneous circles create logistical burdens on transplant centers that do not need them, while small homogeneous circles increase geographic disparity. Using carefully designed heterogeneous circles can reduce geographic disparity in liver supply/demand ratios, compared to homogeneous circles of radius ranging from 150-1,000 nm.HLA-DQB1*05272 has a single transversion compared to the most similar variant, HLA-DQB1*050101 in IPD-IMGT/HLA database. To evaluate the effectiveness of the application of topical heat, high pressure or a combination of both on antebrachial venous cannulation. A cross-over clinical trial blinded for haemolysis analysis. This cross-over clinical trial with two periods was performed in the Clinical Trial Unit of Hospital Universitario de La Princesa (Madrid) during June-July of 2017 in 59 healthy adults who were randomly allocated to one of three interventions (1) Using dry topical heat for 7min produced by two hot seed bags (N=21), (2) Applying controlled pressure from a sphygmomanometer inflated to 100mmHg (N=18) and (3) combining heat and pressure (N=20) in one period out of two. All interventions were contrasted to standard clinical practice in the other period. The comparator involved a standard tourniquet around the upper arm to restrict venous blood flow. The primary outcome was effectiveness measured as vein cannulation at first attempt. Secondary outcomes were vein perception, pain, haemolysis in blood samples andwho often suffer from arterial hypertension. Ultrasonic scalers often cause an uncomfortable feeling to patients during the procedure. This study was conducted to compare patient complaint levels between magnetostrictive (M-USSC) and piezoelectric ultrasonic scalers (P-USSC) during supragingival scaling. This study enrolled 82 subjects who received supportive periodontal therapy for at least 2years. At each recall visit, probing pocket depth (PPD), bleeding on probing (BOP) and O'Leary plaque control record (O'PCR) were recorded. Then, supragingival scaling was performed using P-USSC (Varios or Petit Piezo) at the first visit and M-USSC (Cavitron) at the second visit. After each treatment, a questionnaire survey was performed using the Wong-Baker Faces Pain Scale for six items, which included the typical complaints occurring during ultrasonic scaling. The scores for all the six items related to patient complaints were greater for P-USSC than for M-USSC (p<0.001). Patient complaints such as discomfort, pain, sound, vibration, hyperesthesia and length of treatment time were ameliorated in 74%, 65%, 80%, 67%, 57% and 53% of subjects using M-USSC, respectively.
テキスト整形のルールを表示する